InvestorsHub Logo
Followers 334
Posts 18989
Boards Moderated 0
Alias Born 08/25/2007

Re: None

Thursday, 08/25/2016 11:29:08 AM

Thursday, August 25, 2016 11:29:08 AM

Post# of 2793
SNSS,Vosaroxin Drug , highlight its potential as a new and differentiated treatment option for certain cancers ," stated Dr. Stephen A. Strickland, M.D., MSCI, Clinical Director of Acute Leukemia, Division of Hematology/Oncology at the Vanderbilt-Ingram Cancer Center, Assistant Professor of Medicine, Vanderbilt University Department of Medicine, and a lead author of the publication
http://www.marketwatch.com/story/sunesis-announces-publication-in-drugs-detailing-molecular-and-pharmacologic-properties-of-vosaroxin-2016-08-25-7184046

DONT LISTEN TO ME IM CANADIANNNNNNNN